Delaware Board of Massage and Bodywork s10

Delaware Board of Massage and Bodywork s10

<p> Posted 9/13/06 MK</p><p>CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION</p><p>PUBLIC MEETING NOTICE: BOARD OF PHARMACY</p><p>DATE AND TIME: Wednesday, September 20, 2006 at 9:30 a.m.</p><p>PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building</p><p>AMENDED AGENDA (Amended items are noted by an asterisk)</p><p>1.0 Call to Order</p><p>2.0 Review and Approval of Minutes </p><p>2.1 Meeting Minutes – July 19, 2006</p><p>3.0 Unfinished Business</p><p>3.1 Regulation 9</p><p>3.2 Regulation 8 – Board Hearing 9:30 a.m.</p><p>4.0 New Business </p><p>4.1 Pharmacist-in-Charge Interviews</p><p>4.1.1 Parag Karnik </p><p>4.1.2 Cheryl Hoechner</p><p>4.1.3 Vincent Madaline*</p><p>4.2 Pharmacist Licensure Review - Reciprocal Applications</p><p>4.2.1 Christopher Thomas Board of Pharmacy Agenda – September 13, 2006 Page 2</p><p>4.2.2 Ali Seyedroudbari</p><p>4.2.3 Leena Amin</p><p>4.2.4 Leesa McIlwain</p><p>4.2.5 Jo Ann Maack</p><p>4.2.6 Mark McKinney</p><p>4.2.7 Madhurima Agumamidi</p><p>4.3 Pharmacist Licensure Review - NAPLEX Applications</p><p>4.3.1 William Harbester</p><p>4.3.2 Josephat Waigwa</p><p>4.3.3 Dana Rumsey</p><p>4.3.4 Ravikiran Tatikonda</p><p>4.3.5 Jeannettee Joyner</p><p>4.3.6 Aditi Shahane*</p><p>4.3.7 Adijat Abass*</p><p>4.4 Pharmacist Licensure Review - Score Transfer Applications</p><p>4.4.1 N/A</p><p>4.5 Review of Pharmacy Applications</p><p>4.5.1 Giant of Maryland </p><p>4.5.2 Precision Rx</p><p>4.5.3 College Pharmacy</p><p>4.5.4 McGuff</p><p>4.5.5 B.J.s</p><p>4.5.6 Bayhealth Pharmacy*</p><p>4.6 Pharmacist Consultant Interviews</p><p>4.6.1 N/A</p><p>4.7 District II Meeting Board of Pharmacy Agenda – September 13, 2006 Page 3</p><p>5.0 Committee Reports</p><p>5.1 Joint Practice – Jack Murphy</p><p>5.2 Physician’s Assistant – Karen Dey</p><p>5.3 Newsletter – Angelo Chiari, Don Holst, and David Dryden</p><p>5.4 Legislative – Chris Tigani, Karen Dey, Jack Murphy, Don Holst, and David Dryden</p><p>5.5 Continuing Education – Jack Murphy, Don Holst, and Nancy Weldin</p><p>5.6 Consumer Affairs – Nancy Weldin and Carolyn Calio</p><p>5.7 Professional Liaison – Angelo Chiari and Karen Dey</p><p>5.8 MPJE Study – Karen Dey and Angelo Chiari</p><p>6.0 Inspection Report</p><p>7.0 Board Correspondence</p><p>8.0 Other Business before the Board (for discussion only)</p><p>9.0 Public Comments</p><p>10.0 Review of Consent Order – Complaint No. 13-02-06</p><p>11.0 Next Meeting – October 18, 2006</p><p>12.0 Adjournment</p><p>Please Take Note: Applications for this agenda must be complete and received by 4:30 p.m. on the third business day previous to the meeting date; thus a final amended agenda will be published to reflect any items received after posting of the original agenda. Unforeseen circumstances may result in a meeting being cancelled should there be a lack of quorum. </p><p>Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however, such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the body’s meeting.</p><p>MEMBERS: PLEASE CALL THE OFFICE OF THE DELAWARE BOARD OF PHARMACY AT 302-744-4526 OR EMAIL [email protected] IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.</p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    3 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us